This is a preview of subscription content, log in via an institution to check access.
References
Caramaschi P, Codella O, Poli G, Perbellini L, Biasi D, Bambara LM, Corrocher R, De Sandre G. Use of computerized digital thermometry for diagnosis of Raynaud's phenomenon. Angiology, 1989; 40: 863–872.
Seibold JR, Scleroderma. In: WN, Kelley, ED Harris, S Ruddy, CB Sledge, editors Textbook of Rheumatology, Philadelphia, W.B. Saunders, Company, 1993: 1131.
Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 1992; 19: 1407–1414.
Thurm CA, Wigley FM, Dole WP, Wise RA. Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis. Am J Med 1991; 90: 547–552.
Rademaker M, Thomas RHM, Provost G, Beachman JA, Cooke ED, Kirby JD. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis. Postgrad Med J 1987; 63: 617–620.
Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP. Comparison of equimolar concentrations of iloprost, Prostacyclin and prostaglandin E1 on human platelet function. J Lab Clin Med 1987; 109: 184–190.
Musial J, Wilczynska M, Sladek K, Cierniawski CS, Nizankowski R, Szczeklik A. Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins 1986; 31: 61–70.
Rademaker M, Cooke ED, Almond NE, Beachman JA, Smith RE, Mant TGK, Kirby JD. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomized study. Br Med J 1989; 298: 561–564.
Clements PJ. Measuring disease activity and severity in scleroderma. Curr Opin Rheumatol 1995; 7: 517–521.
Smith E, Gallenkamper W, Bechmann R, Thomsen T, Mannesmann G, Schror K. Early and late administration of PGI1 analoge ZK 36374 (Iloprost): effect on myocardial preservation collateral blood flow and infarct size. Cardiovasc Res 1984; 18: 161–173.
Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 1993; 28: 78–85.
Arpaia G, Cimminiello C, Sardina M, Rossi F, Aloisio M, Curri SB, Bonfardeci C. Microcirculatory effects of iloprost in patients with suspected secondary Raynaud's phenomenon. Vasc Surg 1995; 29: 37–42.
McHugh NJ, Csuka M, Watson H, Belcher G, Amadi A, Ring EFJ, Black CM, Maddison PJ. Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic scelrosis. Ann Rheum Dis 1988; 47: 43–47.
Constans T, Diot E, Lasfargues G. Iloprost for scleroderma (letter). Ann Intern Med 1991; 114: 606.
Watson HR, Belcher G. Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon. Ann Rheum Dis 1991; 50: 359–361.
Torley HI, Madhok R, Capell HA, Brouwer RML, Maddison PJ, Black CM, Englert H, Dormandy JA, Watson HR. A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis 1991; 50: 800–804.
Yardumian DA, Isenberg DA, Rustin M, Belcher G, Snaith ML, Dowd PM, Machin SJ. Successful treatment of Raynaud's syndrome with iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol 1988; 27: 220–226.
Wigley FM, Wise RA, Seibold JR, Wise RA, McCloskey DA, Kujala G et al. Intravenous iloprost infusion in patients with Raynaud's phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994; 120: 199–206.
Kyle MV, Belcher G, Hazleman BL. Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. J Rheumatol 1992; 19: 1403–1406.
Fiessinger JN, Shaefer M. and TAO study. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. Lancet 1990; 335: 555–557.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biasi, D., Caramaschi, P., Carletto, A. et al. A case of diffuse systemic sclerosis treated with a 28-day infusion of iloprost. Clin Rheumatol 16, 111–112 (1997). https://doi.org/10.1007/BF02238778
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02238778